Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Claire E Dees"'
Autor:
Sarina A, Piha-Paul, Kyaw Z, Thein, Paul, De Souza, Richard, Kefford, Tara, Gangadhar, Christopher, Smith, Shelly, Schuster, William C, Zamboni, Claire E, Dees, Ben, Markman
Publikováno v:
Investigational new drugs. 39(4)
Background This was a phase I/IIa study to investigate the tolerability, efficacy and pharmacokinetics (PK)/ pharmacodynamics (PD) of CRLX301, CDP-based nanoparticle formulation of docetaxel. Methods The study was conducted in two parts. In part 1, d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45d00f7dcbb7017406fa2044d6cade09
https://pubmed.ncbi.nlm.nih.gov/33594602
https://pubmed.ncbi.nlm.nih.gov/33594602
Autor:
Erika P Hamilton, Judy S Wang, Timothy Pluard, Stephen Johnston, Aki Aki Morikawa, Claire E Dees, Robert H Jones, Barbara Haley, Anne Armstrong, Adam L Cohen, Pamela Munster, Gail Wright, Fadi Kayali, Manav Korpal, Lihua Yu, Lisa Cantagallo, Benoit Destenaves, Zhaojie Zhang, Lei Gao, Marc J Pipas, Tarek Sahmouud, Antonio Gualberto, Dejan Juric
Publikováno v:
Cancer Research. 81:PD8-06
Background: Addition of CDK 4/6 inhibitors to endocrine therapy has provided significant improvements in outcomes for patients (pts) with metastatic breast cancer (mBC). However, acquired resistance to front-line therapy remains a challenge, and resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cdb284c5182b865f38431bf7567d72a
https://doi.org/10.1158/1538-7445.sabcs20-pd8-06
https://doi.org/10.1158/1538-7445.sabcs20-pd8-06